Aerocrine AB (AERO B) - Medical Equipment - Deals and Alliances Profile

Date: July 3, 2015
Pages: 61
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A094832E292EN
Leaflet:

Download PDF Leaflet

Aerocrine AB (AERO B) - Medical Equipment - Deals and Alliances Profile
Summary

Aerocrine AB (Aerocrine) is a medical technology company. It sells medical technology products and tests for the application in healthcare industry. The company offers its products for diagnosis, treatment and monitoring of patients suffering from inflammation of airways. Its flagship products are marketed under the brand names, NIOX MINO, and NIOX VERO, handheld instruments which measure nitric oxide (NO) levels in exhaled air. Aerocrine’s products also find applications in research performed on respiratory diseases. The company offers these products to hospitals, research clinics, and healthcare units. It operates through wholly owned subsidiaries in the US, the UK, Sweden. Switzerland, and German markets and through suppliers and distributors in other regions such as Japan, Canada, Poland, Portugal, Spain, Australia, and South America among others. Aerocrine is headquartered in Solna, Sweden.

The company focuses on expanding its market presence by entering into agreements with established players in the industry. This is evident from recent signing of an exclusive agreement with Healthcare 21 Ltd for sales, marketing and distribution of its new airway inflammation monitor and test kit NIOX VERO in the UK and Ireland.

Aerocrine AB (AERO B) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
Aerocrine AB, Medical Equipment, Deals By Year, 2009 to YTD 2015
Aerocrine AB, Medical Equipment Deals By Type, 2009 to YTD 2015
Aerocrine AB, Medical Equipment, Deals By Region, 2009 to YTD 2015
Aerocrine AB, Medical Equipment, Deals By Market, 2009 to YTD 2015
Aerocrine AB, Medical Equipment, Deals Summary, 2009 to YTD 2015
Aerocrine AB, Medical Equipment, Deal Details
Asset Purchase
Aerocrine Acquires FENO Assets From FILT
Aerocrine Completes Acquisition Of Assets From Apieron
Partnerships
Aerocrine Enters Into Licensing Agreement With Medisoft
Aerocrine Enters Into Distribution Agreement With Shanghai Pharma For Niox Mino And Test Kits
Aerocrine Enters Into Distribution Agreement With Stallergenes For Niox Mino
Aerocrine To Terminate Distribution Agreement With Thermo Fisher For Niox Mino
Aerocrine Enters Into Co-Development Agreement With FILT
Aerocrine Enters Into Co-Development Agreement With Panasonic Shikoku Electronics
Equity Offering
Aerocrine Completes Private Placement Of Shares For US$15 Million
Aerocrine Completes Rights Offering Of Common Stock For US$36 Million
Aerocrine Completes Private Placement Of US$16 Million
Aerocrine Completes Rights Issue Of US$19 Million
Debt Offering
Aerocrine Completes Private Placement Of Convertible Bonds For US$16 Million
Acquisition
Circassia Pharma to Acquire Aerocrine for USD216 Million
Aerocrine AB - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Strategy And Business Planning
Sep 29, 2014: Aerocrine and Microsoft collaborate to test secure, cloud-based remote medical device monitoring
Financial Announcements
Feb 20, 2015: Aerocrine Achieves Record Sales for the 4th Quarter and Full Year
Jan 07, 2015: Aerocrine Reports Record Sales for the 4th Quarter and Full Year 2014
Nov 27, 2014: Aerocrine Interim Report January – September 2014
Nov 27, 2014: Interim report January September 2014
Jul 24, 2014: Aerocrine Interim report January– June 2014
Corporate Communications
Jun 26, 2015: Aerocrine applies for delisting
Apr 16, 2015: Changes in Aerocrine’s Executive Leadership Team
Dec 12, 2014: Aerocrine announces change in the board of directors
Jun 12, 2014: Aerocrine Announces Leadership Changes
Jun 11, 2014: Aerocrine Announces Management Changes
Product News
Apr 22, 2015: Aerocrine: Sales start of NIOX VERO in Japan
Mar 06, 2015: Aerocrine Receives FDA Clearance for NIOX VERO BlueTooth Wireless Enhancement
Jan 29, 2015: Aerocrine Receives Japanese Health Authority Clearance For NIOX VERO
Dec 15, 2014: Aerocrine resumes sales and marketing of NIOX MINO in China after re-registration approval
Nov 06, 2014: Aerocrine's Niox Vero Device Gets FDA Marketing Clearance
Jul 02, 2014: New clinical review gives practising physicians’ recommendations for how to use Aerocrine’s FeNO-test in routine clinical practice
Apr 02, 2014: Aerocrine: NICE Recommends the Use of NIOX MINO to Help Diagnose and Manage Asthma
Apr 02, 2014: Aerocrine: NICE Recommends the Use of NIOX VERO to Help Diagnose and Manage Asthma
Mar 21, 2014: NICE Will Support the Use of Aerocrine’s NIOX VERO In Diagnosis and Management of Asthma
Mar 21, 2014: NICE Will Support the Use of Fractional Exhaled Nitric Oxide Measurement in Diagnosis and Management of Asthma
Product Approvals
Mar 06, 2015: Aerocrine Receives FDA Clearance for NIOX VERO BlueTooth Wireless Enhancement
Jan 29, 2015: Aerocrine Receives Japanese Health Authority Clearance For NIOX VERO
Nov 06, 2014: Aerocrine's Niox Vero Device Gets FDA Marketing Clearance
Clinical Trials
Jul 02, 2014: New clinical review gives practising physicians’ recommendations for how to use Aerocrine’s FeNO-test in routine clinical practice
Other Significant Developments
May 12, 2015: Aerocrine Sales Grow to Record Levels Again for 1st Quarter, NIOX VERO Launch in the US Off to A Strong Start
Jan 17, 2014: Aerocrine signs UK & Irish partnership deal with Healthcare 21.
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Aerocrine AB, Medical Equipment, Key Facts, 2014
Aerocrine AB, Medical Equipment, Deals Summary, 2009 to YTD 2015
Aerocrine AB, Medical Equipment, Deals By Year, 2009 to YTD 2015
Aerocrine AB, Medical Equipment Deals By Type, 2009 to YTD 2015
Aerocrine AB, Medical Equipment, Deals By Region, 2009 to YTD 2015
Aerocrine AB, Deals By Market, 2009 to YTD 2015
Aerocrine AB, Medical Equipment, Deals Summary, 2009 to YTD 2015
Aerocrine Acquires FENO Assets From FILT
Aerocrine Completes Acquisition Of Assets From Apieron
Aerocrine Enters Into Licensing Agreement With Medisoft
Aerocrine Enters Into Distribution Agreement With Shanghai Pharma For Niox Mino And Test Kits
Aerocrine Enters Into Distribution Agreement With Stallergenes For Niox Mino
Aerocrine To Terminate Distribution Agreement With Thermo Fisher For Niox Mino
Aerocrine Enters Into Co-Development Agreement With FILT
Aerocrine Enters Into Co-Development Agreement With Panasonic Shikoku Electronics
Aerocrine Completes Private Placement Of Shares For US$15 Million
Aerocrine Completes Rights Offering Of Common Stock For US$36 Million
Aerocrine Completes Private Placement Of US$16 Million
Aerocrine Completes Rights Issue Of US$19 Million
Aerocrine Completes Private Placement Of Convertible Bonds For US$16 Million
Circassia Pharma to Acquire Aerocrine for USD216 Million
Aerocrine AB, Key Competitors
Aerocrine AB, Key Employees
Aerocrine AB, Subsidiaries

LIST OF FIGURES

Aerocrine AB, Medical Equipment, Deals by Type, 2009 to YTD 2015
Aerocrine AB, Medical Equipment, Deals By Year, 2009 to YTD 2015
Aerocrine AB, Medical Equipment, Deals By Region, 2009 to YTD 2015
Aerocrine AB, Medical Equipment, Deals By Market, 2009 to YTD 2015
Aerocrine AB, Medical Equipment, Deals By Year, 2009 to YTD 2015
Aerocrine AB, Medical Equipment, Deals by Type, 2009 to YTD 2015
Aerocrine AB, Medical Equipment, Deals By Region, 2009 to YTD 2015
Aerocrine AB, Medical Equipment, Deals by Market, 2009 to YTD 2015
Skip to top


Ask Your Question

Aerocrine AB (AERO B) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: